The glucose monitoring product segment by application is estimated to lead the market growth during the forecast period.
According to this study, the South and Central America point-of-care data management software market is expected to reach US$ 27.12 million in 2027 from US$ 17.24 million in 2020; it is estimated to grow with a CAGR of 6.7% from 2020 to 2027. The report highlights trends prevailing in the South and Central America point-of-care data management software market and the factors driving market along with those that act as hindrances.
The South and Central America point-of-care data management software market, based on application was segmented into infectious disease devices, glucose monitoring, coagulation monitoring, urinalysis, cardiometabolic monitoring, cancer markers, and hematology. In 2019, the glucose monitoring product segment held the largest share of the market, however, the cancer markers segment is registering the highest CAGR in the market during the forecast period.
Point-of-care (POC) data management software facilitates the patients' health data management and analysis. Factors such as the increasing number of contagious diseases; rising incidence of lifestyle-related diseases, such as cardiac diseases and diabetes; and growing demand for quick services drive the need for POC data management software. For instance, according to International Diabetes Federation in 2019, ~ 463 million adults (20-79 years) are suffering from diabetes; by 2045 the count will rise to 700 million across the globe. Moreover, the increasing incidence of infectious diseases, such as HIV, is another major public health issue. Thus, the factors mentioned above are likely to boost the growth of the market during the forecast period. Also, the growth of the South and Central America point-of-care data management software market is likely to proceed with the help of the introduction of new products into the market, which aim to deliver inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier-to-use devices with incremental improvements in analytical performance. Such advancements in newly launched devices would propel the overall market growth during the forecast period.
South and Central America is facing significantly challenging situation due to COVID-19 pandemic. Hence, the demand for devices such as glucose monitoring, coagulation monitoring, urinalysis, cardiometabolic monitoring, cancer markers, and hematology has been affected. However, in some emergency, governments are taking measures to help patients, as in-person doctor’s appointments are being now conducted over phone call or video consultation. Additionally, a few countries across South and Central America are limiting the sales/purchase of software as a device in response to COVID-19 to maintain supply and counteract stockpiling/panic buying. Thus, the above-mentioned factors are likely to hamper the growth of the point-of-care data management software market in South and Central America.
The growth of the market is attributed to the increasing incidence of infectious diseases and lifestyle-related diseases, and rising product launches and development for data management. However, the high cost of point-of-care data management systems hinders the market growth.
Abbott, Siemens Healthineers AG, F. HOFFMANN-LA ROCHE LTD., Randox Laboratories Ltd, Radiometer Medical ApS, and THERMO FISHER SCIENTIFIC INC.,are among the leading companies operating in the South and Central America point-of-care data management software market.
The report segments in South and Central America point-of-care data management software market as follows:
By Application
By End User
By Country
The South and Central America point-of-care data management software market, based on application was segmented into infectious disease devices, glucose monitoring, coagulation monitoring, urinalysis, cardiometabolic monitoring, cancer markers, and hematology. In 2019, the glucose monitoring product segment held the largest share of the market, however, the cancer markers segment is registering the highest CAGR in the market during the forecast period.
Point-of-care (POC) data management software facilitates the patients' health data management and analysis. Factors such as the increasing number of contagious diseases; rising incidence of lifestyle-related diseases, such as cardiac diseases and diabetes; and growing demand for quick services drive the need for POC data management software. For instance, according to International Diabetes Federation in 2019, ~ 463 million adults (20-79 years) are suffering from diabetes; by 2045 the count will rise to 700 million across the globe. Moreover, the increasing incidence of infectious diseases, such as HIV, is another major public health issue. Thus, the factors mentioned above are likely to boost the growth of the market during the forecast period. Also, the growth of the South and Central America point-of-care data management software market is likely to proceed with the help of the introduction of new products into the market, which aim to deliver inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier-to-use devices with incremental improvements in analytical performance. Such advancements in newly launched devices would propel the overall market growth during the forecast period.
South and Central America is facing significantly challenging situation due to COVID-19 pandemic. Hence, the demand for devices such as glucose monitoring, coagulation monitoring, urinalysis, cardiometabolic monitoring, cancer markers, and hematology has been affected. However, in some emergency, governments are taking measures to help patients, as in-person doctor’s appointments are being now conducted over phone call or video consultation. Additionally, a few countries across South and Central America are limiting the sales/purchase of software as a device in response to COVID-19 to maintain supply and counteract stockpiling/panic buying. Thus, the above-mentioned factors are likely to hamper the growth of the point-of-care data management software market in South and Central America.
The growth of the market is attributed to the increasing incidence of infectious diseases and lifestyle-related diseases, and rising product launches and development for data management. However, the high cost of point-of-care data management systems hinders the market growth.
Abbott, Siemens Healthineers AG, F. HOFFMANN-LA ROCHE LTD., Randox Laboratories Ltd, Radiometer Medical ApS, and THERMO FISHER SCIENTIFIC INC.,are among the leading companies operating in the South and Central America point-of-care data management software market.
The report segments in South and Central America point-of-care data management software market as follows:
By Application
- Glucose Monitoring
- Hematology
- Cardiometabolic Monitoring
- Infectious Disease Devices
- Coagulation Monitoring
- Cancer Markers
- Urinalysis
- Others
By End User
- Hospitals/Critical Care Units
- Diagnostic Centers
- Clinics/Outpatient
By Country
- Brazil
- Argentina
- Rest of South and Central America
Table of Contents
1. Introduction
3. Research Methodology
4. South and Central America Point-of-Care Data Management Software Market- Market Landscape
5. Point of Care Data Management Software Market - Key Industry Dynamics
6. Point-of-Care Data Management Software Market - South and Central America Analysis
7. Point-of-Care Data Management Software Market Analysis- by Application
8. Point-of-Care Data Management Software Market Analysis- by End User
9. Point-of-Care Data Management Software Market - South and Central America Analysis
10. Impact of COVID-19 Pandemic on Point-of-Care Data Management Software Market
11. Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Siemens Healthineers AG
- F. HOFFMANN-LA ROCHE LTD.
- Randox Laboratories Ltd
- Radiometer Medical ApS
- THERMO FISHER SCIENTIFIC INC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | June 2021 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 17.24 Million |
| Forecasted Market Value ( USD | $ 27.12 Million |
| Compound Annual Growth Rate | 6.7% |
